Related Experiment Video
Updated: May 3, 2026

13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
11.4K
Conclusions about the quadrivalent human papillomavirus vaccine efficacy based on alternate dosing schedules and less
1Rowntree Endowed Chair and Professor of Family and Geriatric Medicine and Obstetrics and Gynecology, Epidemiology and Population Health and Health Promotion and Behavioral Sciences, University of Louisville Schools of Medicine and Public Health.
The Journal of Infectious Diseases
|February 7, 2014
Abstract
No abstract available in PubMed .
Related Concept Videos
Vaccinations
44.1K
Overview
44.1K
Dosage Regimens: Partial Pharmacokinetic Parameters
363
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
363
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

